Labcorp Files 8-K on Financial Results and Exhibits

Ticker: LH · Form: 8-K · Filed: 2024-02-15T00:00:00.000Z

Sentiment: neutral

Topics: financial-results, 8-K filing, disclosure, corporate-action

TL;DR

**Labcorp just filed an 8-K on Feb 15, 2024, detailing their financial results and statements.**

AI Summary

Laboratory Corporation of America Holdings (Labcorp) filed an 8-K on February 15, 2024, reporting on "Results of Operations and Financial Condition" and "Financial Statements and Exhibits." This filing indicates the company is providing updated financial information to the SEC, as required by Section 13 or 15(d) of the Securities Exchange Act of 1934. The earliest event reported in this filing also occurred on February 15, 2024.

Why It Matters

This filing signals that Labcorp is disclosing its latest financial performance and related statements, providing transparency to investors and the market. It allows stakeholders to review the company's current financial health and operational results.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial results and exhibits, not indicating any specific adverse events or significant changes in company operations.

Key Players & Entities

FAQ

What is the exact name of the registrant as specified in its charter?

The exact name of the registrant is LABORATORY CORPORATION OF AMERICA HOLDINGS.

What was the date of the earliest event reported in this 8-K filing?

The date of the earliest event reported was February 15, 2024.

What items were reported in this 8-K filing?

The 8-K reported on "Results of Operations and Financial Condition" and "Financial Statements and Exhibits."

What is the state of incorporation for Laboratory Corporation of America Holdings?

Laboratory Corporation of America Holdings is incorporated in Delaware.

What is the Commission File Number for the registrant?

The Commission File Number for Laboratory Corporation of America Holdings is 1-11353.

From the Filing

0000920148-24-000009.txt : 20240215 0000920148-24-000009.hdr.sgml : 20240215 20240215070108 ACCESSION NUMBER: 0000920148-24-000009 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240215 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 133757370 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 24642018 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 lh-20240215.htm 8-K lh-20240215 February 15, 2024 0000920148 FALSE 0000920148 2024-02-15 2024-02-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 15, 2024 (Date of earliest event reported) LABORATORY CORPORATION OF AMERICA HOLDINGS (Exact Name of Registrant as Specified in its Charter) Delaware 1-11353 13-3757370 (State or other jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 358 South Main Street   Burlington, North Carolina 27215 (Address of principal executive offices) (Zip Code) (Registrant’s telephone number including area code) 336 - 229-1127 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Exchange Act. Title of Each Class            Trading Symbol            Name of exchange on which registered Common Stock, $0.10 par value          LH                  New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).                                                      Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 2.02 Results of Operations and Financial Condition Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated February 1 5 , 202 4 issued by Labcorp SIGNATURES Pursuant to the

View on Read The Filing